Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,596.84
    -1,603.16 (-3.19%)
     
  • CMC Crypto 200

    1,261.04
    -96.97 (-7.14%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Company News for Jun 24, 2020

  • Spirit AeroSystems Holdings Inc.'s SPR shares plunged 13.3% after the company announced that The Boeing Co. BA asked it to produce fewer 737 MAX aeroplanes.

  • Shares of Electronic Arts Inc. EA rose 0.7% after the company declared that its fiscal first-quarter 2021 (ending June) results will be better-than its earlier expectations.

  • Shares of Translate Bio Inc. TBIO soared 47% after the company expanded its collaboration with Sanofi SNY related to mRNA vaccines to treat infectious diseases.

  • Myovant Sciences Ltd. MYOV shares jumped 14.3% after the FDA accepted NDA of is drug oral relugolix (120 mg) for the treatment of men with advanced prostate cancer.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
The Boeing Company (BA) : Free Stock Analysis Report
 
Sanofi (SNY) : Free Stock Analysis Report
 
Spirit Aerosystems Holdings, Inc. (SPR) : Free Stock Analysis Report
 
Translate Bio, Inc. (TBIO) : Free Stock Analysis Report
 
Electronic Arts Inc. (EA) : Free Stock Analysis Report
 
Myovant Sciences Ltd. (MYOV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research